Status:
RECRUITING
China Adrenal Disease Registry
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Cushing Syndrome
Aldosteronism
Eligibility:
All Genders
16-75 years
Brief Summary
Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal di...
Detailed Description
In order to meet all the challenges in the diagnosis and treatment of adrenal diseases in China, CASE was founded in 2020. With advanced medical equipment and Internet of Things (IoT) technology, CASE...
Eligibility Criteria
Inclusion
- Age ≥ 16 years old and ≤ 75 years
- Patients diagnosed with adrenal associated diseases, including cushing syndrome, primary aldosteronism, primary hypoadrenalism, congenital adrenal hyperplasia and adrenal adenomas, incidentalomas, and carcinomas, pheochromocytoma, etc.
- Provide written informed consent
- Satisfactory compliance
Exclusion
- Patients with significantly reduced life expectancy (less than 2 years)
- With Drug abuse
- With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04890444
Start Date
June 1 2021
End Date
April 30 2026
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endocrinology
Shanghai, China